AsedaSciences®
Daniel H Robertson is an experienced professional who has held various roles in the fields of applied data sciences, computational drug discovery, informatics, small molecule discovery, and molecular modeling. With a strong educational background in Chemistry, including a Ph.D. from Florida State University, Daniel has worked at reputable companies such as Eli Lilly and Company, BioCrossroads, Indiana Biosciences Research Institute, and AsedaSciences. Daniel H has contributed significantly to the growth and development of organizations, focusing on catalyzing disruptive change in life sciences and healthcare through data sciences and innovative projects. Additionally, Daniel co-founded Indycoupons.com and has experience in webmastering and local promotional activities.
This person is not in any teams
This person is not in any offices
AsedaSciences®
AsedaSciences was established with the vision of becoming a leader in optimized drug discovery through innovative cellular analysis. We provide multi-parametric, high content, high throughput phenotypic screening services to the pharmaceutical and bio-pharmaceutical industry for the assessment of compound toxicity or mechanism of action. Our unique platform utilizes the inherent strengths of flow cytometry, automated processes and sophisticated data analysis to deliver high value information that allows for earlier and more informed decisions during the drug discovery and development process. Innovative Cellular Analysis: Our systems-based approach to multi-parametric cellular analysis delivers high content, high value information on the biological effect of compounds on human cells to aid in compound classification early in drug discovery. Biological Fingerprints: We examine compound effects on integrated intra-cellular networks, targets and pathways to generate biological fingerprints that can be used for comparison to a database of known toxins and marketed therapeutics. Multiplexed Phenotypic Screens: We perform robust, high throughput, high content, multi-parametric phenotypic screens for the assessment of compound toxicity or mechanism of action. Our automated, operator independent analysis converts highly complex data into information for effective management of compound progression. Visit www.asedasciences.com for more details.